THE PENNANT GROUP, INC. Interest Expense
THE PENNANT GROUP, INC. (PNTG) reported Interest Expense of $1.79 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-06
- THE PENNANT GROUP, INC. interest expense for the quarter ending 2024-03-31 was $1.79M, a 27.45% increase year-over-year.
- THE PENNANT GROUP, INC. interest expense for the quarter ending 2023-12-31 was $1.57M, a 19.95% increase year-over-year.
- THE PENNANT GROUP, INC. interest expense for the quarter ending 2023-09-30 was $1.50M, a 41.40% increase year-over-year.
- THE PENNANT GROUP, INC. interest expense for the quarter ending 2023-06-30 was $1.45M, a 76.98% increase year-over-year.
- THE PENNANT GROUP, INC. interest expense for fiscal 2023 was $5.92M, a 55.24% increase from fiscal 2022.
- THE PENNANT GROUP, INC. interest expense for fiscal 2022 was $3.82M, a 96.60% increase from fiscal 2021.
- THE PENNANT GROUP, INC. interest expense for fiscal 2021 was $1.94M, a 56.66% increase from fiscal 2020.
- THE PENNANT GROUP, INC. interest expense for fiscal 2020 was $1.24M, a 202.20% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.79M 10-Q · filed 2024-05-06 | $3.36M derived: sum of 2 quarters · filed 2024-05-06 | $4.86M derived: sum of 3 quarters · filed 2024-05-06 | $6.31M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.06M derived: sum of 2 quarters · filed 2024-02-28 | $4.52M derived: sum of 3 quarters · filed 2024-02-28 | $5.92M 10-K · filed 2024-02-28 |
| 2023-09-30 | $1.50M 10-Q · filed 2023-11-07 | $2.95M derived: sum of 2 quarters · filed 2023-11-07 | $4.36M 10-Q · filed 2023-11-07 | $5.66M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-06-30 | $1.45M 10-Q · filed 2023-08-08 | $2.86M 10-Q · filed 2023-08-08 | $4.17M derived: sum of 3 quarters · filed 2024-05-06 | $5.22M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-03-31 | $1.41M 10-Q · filed 2024-05-06 | $2.71M derived: sum of 2 quarters · filed 2024-05-06 | $3.77M derived: sum of 3 quarters · filed 2024-05-06 | $4.59M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.37M derived: sum of 2 quarters · filed 2024-02-28 | $3.19M derived: sum of 3 quarters · filed 2024-02-28 | $3.82M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.06M 10-Q · filed 2023-11-07 | $1.88M derived: sum of 2 quarters · filed 2023-11-07 | $2.51M 10-Q · filed 2023-11-07 | $3.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $821.00K 10-Q · filed 2023-08-08 | $1.45M 10-Q · filed 2023-08-08 | $2.05M derived: sum of 3 quarters · filed 2024-02-28 | $2.56M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $629.00K 10-Q · filed 2023-05-04 | $1.23M derived: sum of 2 quarters · filed 2024-02-28 | $1.74M derived: sum of 3 quarters · filed 2024-02-28 | $2.21M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $597.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.11M derived: sum of 2 quarters · filed 2024-02-28 | $1.58M derived: sum of 3 quarters · filed 2024-02-28 | $1.94M 10-K · filed 2024-02-28 |
| 2021-09-30 | $512.00K 10-Q · filed 2022-11-07 | $984.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.34M 10-Q · filed 2022-11-07 | $1.69M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $472.00K 10-Q · filed 2022-08-08 | $832.00K 10-Q · filed 2022-08-08 | $1.18M derived: sum of 3 quarters · filed 2023-02-23 | $1.37M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $360.00K 10-Q · filed 2022-05-09 | $703.00K derived: sum of 2 quarters · filed 2023-02-23 | $895.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.20M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $535.00K derived: sum of 2 quarters · filed 2023-02-23 | $836.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.24M 10-K · filed 2023-02-23 |
| 2020-09-30 | $192.00K 10-Q · filed 2021-11-08 | $493.00K derived: sum of 2 quarters · filed 2021-11-08 | $896.00K 10-Q · filed 2021-11-08 | $1.31M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $301.00K 10-Q · filed 2021-08-09 | $704.00K 10-Q · filed 2021-08-09 | $1.11M derived: sum of 3 quarters · filed 2022-02-28 | $1.11M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $403.00K 10-Q · filed 2021-05-06 | $813.00K derived: sum of 2 quarters · filed 2022-02-28 | $813.00K derived: sum of 3 quarters · filed 2022-02-28 | |
| 2019-12-31 | $410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $410.00K derived: sum of 2 quarters · filed 2022-02-28 | $410.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |